P Bruzzi
Overview
Explore the profile of P Bruzzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
2585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Sanctis R, Bruzzi P, Zambelli A
Ann Oncol
. 2024 Sep;
35(12):1201-1202.
PMID: 39236982
No abstract available.
2.
Radaelli S, Fossati P, Stacchiotti S, Akiyama T, Asencio J, Bandiera S, et al.
Eur J Surg Oncol
. 2020 May;
46(8):1415-1422.
PMID: 32402509
Objective: Aim of the manuscript is to discuss how to improve margins in sacral chordoma. Background: Chordoma is a rare neoplasm, arising in half cases from the sacrum, with reported...
3.
Merlano M, Denaro N, Benasso M, Licitra L, Bossi P, Locati L, et al.
Oral Oncol
. 2019 Sep;
97:99-104.
PMID: 31472438
Purpose/objective: On September 2009: We started a randomized multicenter phase III study comparing chemoradiation (CRT) (Aldestein RTOG regimen) versus induction chemotherapy followed by Cetuximab radiation (IBRT). The main study's aim...
4.
Mandese V, Bigi E, Bruzzi P, Palazzi G, Predieri B, Lucaccioni L, et al.
BMC Pediatr
. 2019 Feb;
19(1):56.
PMID: 30744584
Background: Children with Sickle Cell Disease (SCD) show endocrine complications and metabolic alterations. The physiopathology of these conditions is not completely understood: iron overload due to chronic transfusions, ischemic damage,...
5.
Nanni O, Amadori D, De Censi A, Rocca A, Freschi A, Bologna A, et al.
Breast Cancer Res Treat
. 2018 Dec;
174(2):433-442.
PMID: 30536182
Purpose: To investigate the efficacy of metformin (M) plus chemotherapy versus chemotherapy alone in metastatic breast cancer (MBC). Methods: Non-diabetic women with HER2-negative MBC were randomized to receive non-pegylated liposomal...
6.
Poggio F, Ceppi M, Lambertini M, Bruzzi P, Ugolini D, Bighin C, et al.
Breast
. 2017 Apr;
33:104-108.
PMID: 28360014
Background: Although in clinical practice adjuvant chemotherapy (CT) and endocrine therapy (ET) are administered sequentially in patients with hormone-receptor positive breast cancer, the optimal timing, i.e. concurrent or sequential administration,...
7.
Stacchiotti S, Gronchi A, Fossati P, Akiyama T, Alapetite C, Baumann M, et al.
Ann Oncol
. 2017 Feb;
28(6):1230-1242.
PMID: 28184416
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care...
8.
Giacobbe D, Del Bono V, Bruzzi P, Corcione S, Giannella M, Marchese A, et al.
Eur J Clin Microbiol Infect Dis
. 2016 Dec;
36(4):663-669.
PMID: 27909821
Introduction: the purpose of this retrospective multicenter study was to assess whether the risk of developing bloodstream infections (BSI) due to carbapenem-resistant Klebsiella pneumoniae (CRKP) in colonized patients is influenced...
9.
Lambertini M, Ceppi M, Poggio F, Peccatori F, Azim Jr H, Ugolini D, et al.
Ann Oncol
. 2015 Sep;
26(12):2408-19.
PMID: 26347105
Background: The role of temporary ovarian suppression with luteinizing hormone-releasing hormone agonists (LHRHa) in the prevention of chemotherapy-induced premature ovarian failure (POF) is still controversial. Our meta-analysis of randomized, controlled...
10.
Giacobbe D, Esteves P, Bruzzi P, Mikulska M, Furfaro E, Mesini A, et al.
Clin Microbiol Infect
. 2015 Jun;
21(10):954.e9-17.
PMID: 26070961
A retrospective study was conducted to assess the role of initial serum (1,3)-β-d-glucan (BDG) values in predicting mortality in proven candidaemia. The study was conducted in two large teaching hospitals...